Use of serum is authorized for early treatment of COVID-19
Luis Ostrosky, MD, spoke to Telemundo Houston Channel 47 about Bamlanivimab, a monoclonal antibody treatment for COVID-19 that recently received emergency use authorization from the U.S. Food and Drug Administration. The story was also shared online.
December 17, 2020
Share
Share on Facebook Share on Twitter Share on Google Plus Share on Google Plus Share by Email